Skip to main content
Log in

Mammakarzinomgraduierung an Gewebestanzen

Objektivierung mit dem Proliferationsmarker Ki-67

Improvement of breast cancer grading in punch biopsies

  • Schwerpunkt: Mammapathologie
  • Published:
Der Pathologe Aims and scope Submit manuscript

Zusammenfassung

Das Graduieren invasiver Mammakarzinome nach Bloom und Richardson (Nottingham-Modifikation, N-BRG) gehört zu den wichtigsten Prognosefaktoren neben Ausbreitung und Lymphknotenstatus. Die Reproduzierbarkeit im diagnostischen Alltag stellt bislang ein Problem dar. Häufig sind die geforderten Kriterien zu Auswahl und Umfang der zu graduierenden Fläche in Stanzbiopsien nicht einzuhalten.

Retrospektiv wurde an 346 Fällen ein Vergleich der Routinegraduierung am Operationspräparat mit einer der Stanzbiopsie äquivalenten kleinen Gewebemenge durchgeführt. Daneben wurde eine modifizierte Graduierung dieser kleinen Gewebemengen entwickelt mit Ki-67-Immunhistochemie und Kerngrößenmessung.

Beim modifizierten Grading wurden je 1–3 Punkte für Ki-67 und den durchschnittlichen maximalen Kerndurchmesser vergeben. Die Tubulusbildung wurde mit 1 oder 2 Punkten bewertet. Ein Vergleich mit rezidivfreiem Überleben und Gesamtüberleben zeigte signifikante Prognoseunterschiede zwischen Fällen mit 3–5 Punkten (niedriges Risiko) und 6–8 Punkten (hohes Risiko) in der univariaten und multivariaten Analyse.

An kleinen Gewebeproben wie einer Stanze sind die Auswertekriterien des N-BRG nicht zu erfüllen. In unserer Serie war nur für nodal-negative Fälle ein prognostischer Wert nachweisbar. Nach Modifikation durch objektivierbare Parameter wie Kerngrößenmessung und Ki-67-Proliferationsindex kann aber auch an kleinen Gewebeproben eine signifikante Prognoseabschätzung sowohl für nodal-negative als auch nodal-positive Fälle erfolgen.

Abstract

The grading of invasive breast cancers according to Bloom and Richardson (Nottingham modification) provides one of the most important prognostic factors in addition to size and the status of the lymph nodes. Diagnostic reproducibility has been problematic in daily practice as the required criteria for selection and extent of the grading area are frequently not present in the punch biopsies.

A total of 346 cases were retrospectively used to compare routine grading from surgical preparations with an equivalently small sample from punch biopsies. In addition, a modified grading of these small samples was developed with Ki-67 immunochemistry and the measurement of core size.

In the case of modified grading, 1–3 points were given for Ki-67 and average maximum core diameter. Tubule development was evaluated with 1 or 2 points. A comparison for recurrence free survival and total survival showed significant prognostic differences between 3–5 points (low risk) and 6–8 points (high risk) in uni- and multivariate analyses.

The evaluation criteria for Nottingham-Bloom-Richardson grading in a small tissue sample, such as that from a punch biopsy, can hardly be fulfilled. In our series, prognostic value was only found for nodal negative cases. After modification using objective parameters such as nuclear size measurement and Ki-67 proliferation index, a small tissue sample can prove to be of significant prognostic value for nodal negative as well as nodal positive cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3
Abb. 4

Literatur

  1. Andrade VP, Gobbi H (2004) Accuracy of typing and grading invasive mammary carcinomas on core needle biopsy compared with the excisional specimen. Virchows Arch 445: 597–602

    Article  PubMed  Google Scholar 

  2. Astall EC, Bobrow LG (1998) Assessment of the accuracy of diagnostic and prognostic information provided by core biopsy in breast carcinoma. J Pathol 1998, 186: A6

    Google Scholar 

  3. Baak JP, Kurver PH, De Snoo-Niewlaat AJ et al. (1982) Prognostic indicators in breast cancer – morphometric methods. Histopathology 6: 327–339

    PubMed  Google Scholar 

  4. Bloom HJ, Richardson WW (1957) Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years. Br J Cancer 11: 359–377

    PubMed  Google Scholar 

  5. Burcombe RJ, Makris A, Richman PI et al. (2005) Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. Br J Cancer 92: 147–155

    Article  PubMed  Google Scholar 

  6. Dalton LW, Page DL, Dupont WD (1994) Histologic grading of breast carcinoma. A reproducibility study. Cancer 73: 2765–2770

    Article  PubMed  Google Scholar 

  7. Denley H, Pinder SE, Elston CW et al. (2001) Preoperative assessment of prognostic factors in breast cancer. J Clin Pathol 54: 20–24

    Article  PubMed  Google Scholar 

  8. Elston CW, Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403–410

    PubMed  Google Scholar 

  9. Frierson HF Jr, Wolber RA, Berean KW et al. (1995) Interobserver reproducibility of the Nottingham modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 103: 195–198

    PubMed  Google Scholar 

  10. Harris GC, Denley HE, Pinder SE et al. (2003) Correlation of histologic prognostic factors in core biopsies and therapeutic excisions of invasive breast carcinoma. Am J Surg Pathol 27: 11–15

    Article  PubMed  Google Scholar 

  11. Kronqvist P, Kuopio T, Collan Y (1998) Morphometric grading of invasive ductal breast cancer. I. Thresholds for nuclear grade. Br J Cancer 78: 800–805

    PubMed  Google Scholar 

  12. Kronqvist P, Kuopio T, Pirvu C, Collan Y (1999) The fraction of fields showing neoplastic tubules: a practical estimate of tubular differentiation in breast cancer. Histopathology 35: 401–410

    Article  PubMed  Google Scholar 

  13. Kronqvist P, Kuopio T, Jalava P, Collan Y (2002) Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer. Br J Cancer 87: 1275–1280

    Article  PubMed  Google Scholar 

  14. Mengel M, von Wasielewski R, Wiese B et al. (2002) Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial. J Pathol 198: 292–299

    Article  PubMed  Google Scholar 

  15. Meyer JS, Alvarez C, Milikowski C et al. (2005) Breast carcinoma malignancy grading by Bloom-Richardson system vs proliferation index: reproducibility of grade and advantages of proliferation index. Mod Pathol 18: 1067–1078

    Article  PubMed  Google Scholar 

  16. Remmele W, Hildebrand U, Hienz HA et al. (1986) Comparative histological, histochemical, immunohistochemical and biochemical studies on oestrogen receptors, lectin receptors, and Barr bodies in human breast cancer. Virchows Arch A Pathol Anat Histopathol 409: 127–147

    Article  PubMed  Google Scholar 

  17. Robbins P, Pinder S, de Klerk N et al. (1995) Histological grading of breast carcinomas: a study of interobserver agreement. Hum Pathol 26: 873–879

    Article  PubMed  Google Scholar 

  18. Roberti NE (1997) The role of histologic grading in the prognosis of patients with carcinoma of the breast: is this a neglected opportunity? Cancer 80: 1708–1716

    Article  PubMed  Google Scholar 

  19. Schneeweiss A, Katretchko J, Sinn HP et al. (2004) Only grading has independent impact on breast cancer survival after adjustment for pathological response to preoperative chemotherapy. Anticancer Drugs 15: 127–135

    Article  PubMed  Google Scholar 

  20. Schondorf H, Naujoks H (1985) Determining the nuclear area in normal breast epithelia and in the nuclei of mammary carcinomas. J Cancer Res Clin Oncol 109: 241–244

    Article  PubMed  Google Scholar 

  21. Sharifi S, Peterson MK, Baum JK et al. (1999) Assessment of pathologic prognostic factors in breast core needle biopsies. Mod Pathol 12: 941–945

    PubMed  Google Scholar 

  22. Trihia H, Murray S, Price K et al. (2003) Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors – a surrogate marker? Cancer 97: 1321–1331

    Article  PubMed  Google Scholar 

  23. Veronese SM, Gambacorta M, Gottardi O et al. (1993) Proliferation index as a prognostic marker in breast cancer. Cancer 71: 3926–3931

    Article  PubMed  Google Scholar 

  24. von Wasielewski R, Mengel M, Wiese B et al. (2002) Tissue array technology for testing interlaboratory and interobserver reproducibility of immunohistochemical estrogen receptor analysis in a large multicenter trial. Am J Clin Pathol 118: 675–682

    Article  PubMed  Google Scholar 

  25. Yoder BJ, Tso E, Skacel M et al. (2005) The expression of fascin, an actin-bundling motility protein, correlates with hormone receptor-negative breast cancer and a more aggressive clinical course. Clin Cancer Res 11: 186–192

    PubMed  Google Scholar 

Download references

Interessenkonflikt

Der korrespondierende Autor weist auf eine Verbindung mit folgender Firma/Firmen hin: Dr. R. von Wasielewski besitzt ein Patent auf die verwandte Technik zur Multiblock Herstellung und ist geschäftsführender Gesellschafter der multiblock GmbH, Hannover.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H. Kreipe.

Rights and permissions

Reprints and permissions

About this article

Cite this article

von Wasielewski, R., Klöpper, K., Lück, H.J. et al. Mammakarzinomgraduierung an Gewebestanzen. Pathologe 27, 337–345 (2006). https://doi.org/10.1007/s00292-006-0855-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00292-006-0855-9

Schlüsselwörter

Keywords

Navigation